Key Takeaways
- About 7% of adults in the United States (roughly 1 in 14) will have PTSD at some point in their lifetime
- About 3.5% of adults in the United States (about 1 in 28) have PTSD in a given year
- PTSD affects women about twice as often as men (lifetime prevalence 9.7% for women vs 3.6% for men)
- In an analysis of the DSM-IV PTSD criteria, intrusion symptoms include at least one of five items (recurrent intrusive distressing memories, nightmares, flashbacks, etc.)
- In DSM-5, PTSD avoidance symptoms require at least one of two items (avoidance of distressing memories/thoughts and/or avoidance of external reminders)
- In DSM-5, negative alterations in cognitions and mood require at least two symptoms from a list
- In the U.S., the 2023 National Veteran Suicide Hotline/988 data show that VA provides 24/7 crisis lines; PTSD is common among those receiving VA mental health crisis services (descriptive)
- WHO identifies PTSD as a consequence of exposure to a traumatic event that threatens life or physical integrity
- WHO reports PTSD is more likely to develop after events involving interpersonal violence
- Cognitive Processing Therapy is a first-line PTSD treatment recommended by VA
- Prolonged Exposure therapy is a first-line PTSD treatment recommended by VA
- Eye Movement Desensitization and Reprocessing (EMDR) is recommended as an evidence-based PTSD treatment
- PTSD is associated with comorbid depression; a NIMH summary notes a high comorbidity rate (often >50% in studies)
- PTSD is associated with increased risk for substance use disorders; NIMH reports substantial overlap in studies
- A VA resource states PTSD commonly co-occurs with major depressive disorder and anxiety disorders
About 7% of U.S. adults develop PTSD over a lifetime, with treatment often lagging behind need.
Prevalence & Burden
Prevalence & Burden Interpretation
Diagnosis & Symptom Profile
Diagnosis & Symptom Profile Interpretation
Risk Factors & Populations
Risk Factors & Populations Interpretation
Treatments, Outcomes & Care
Treatments, Outcomes & Care Interpretation
Comorbidity, Impacts & Service Use
Comorbidity, Impacts & Service Use Interpretation
How We Rate Confidence
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
Stefan Wendt. (2026, February 13). Ptsd Statistics. Gitnux. https://gitnux.org/ptsd-statistics
Stefan Wendt. "Ptsd Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ptsd-statistics.
Stefan Wendt. 2026. "Ptsd Statistics." Gitnux. https://gitnux.org/ptsd-statistics.
References
- 1nimh.nih.gov/health/statistics/post-traumatic-stress-disorder-ptsd
- 30nimh.nih.gov/health/publications/ptsd-post-traumatic-stress-disorder
- 31nimh.nih.gov/health/topics/trauma-and-ptsd
- 2ptsd.va.gov/professional/assessment/epidemiological_studies.asp
- 4ptsd.va.gov/professional/real-world/ptsd-general.asp
- 5ptsd.va.gov/professional/real-world/ptsd-veterans.asp
- 6ptsd.va.gov/professional/real-world/ptsd-women.asp
- 7ptsd.va.gov/professional/treat/tx_basics.asp
- 18ptsd.va.gov/professional/assessment/diagnosis/symptoms-in-dsm-5.asp
- 20ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp
- 21ptsd.va.gov/professional/assessment/overview/ptsd-checklist.asp
- 22ptsd.va.gov/professional/assessment/caps-5.asp
- 23ptsd.va.gov/professional/assessment/index.asp
- 27ptsd.va.gov/professional/trauma/ptsd_risk_factors.asp
- 29ptsd.va.gov/professional/assessment/trauma-risk-factors.asp
- 33ptsd.va.gov/understand_tx/tx/cognitive_processing.asp
- 34ptsd.va.gov/understand_tx/tx/prolonged_exposure.asp
- 35ptsd.va.gov/understand_tx/tx/emdr.asp
- 36ptsd.va.gov/professional/treat/str-strong-start.asp
- 37ptsd.va.gov/professional/treat/child_prolonged_exposure.asp
- 39ptsd.va.gov/professional/treat/txessentials/ssri.asp
- 42ptsd.va.gov/professional/treat/txessentials/venlafaxine.asp
- 48ptsd.va.gov/professional/continuing_ed/continuing_ed.asp
- 49ptsd.va.gov/professional/treat/txessentials/meds.asp
- 50ptsd.va.gov/professional/tx/early-intervention.asp
- 55ptsd.va.gov/professional/treatment/ebp.asp
- 57ptsd.va.gov/public/treatment/sleep_issues.asp
- 58ptsd.va.gov/professional/treat/care-coordination.asp
- 59ptsd.va.gov/professional/assessment/screens.asp
- 60ptsd.va.gov/professional/assessment/overview/comorbidity.asp
- 61ptsd.va.gov/professional/trauma/traumatic-brain-injury.asp
- 62ptsd.va.gov/professional/quality-of-care/ptsd-chronic-pain.asp
- 65ptsd.va.gov/public/sleep_problems.asp
- 66ptsd.va.gov/understand/why_vets.asp
- 67ptsd.va.gov/professional/quality-of-care/ptsd-programs.asp
- 68ptsd.va.gov/professional/programs/ebt.asp
- 3ncbi.nlm.nih.gov/pmc/articles/PMC2945179/
- 8ncbi.nlm.nih.gov/pmc/articles/PMC3779204/
- 9ncbi.nlm.nih.gov/books/NBK450799/
- 13ncbi.nlm.nih.gov/pmc/articles/PMC3813721/
- 16ncbi.nlm.nih.gov/pmc/articles/PMC2836252/
- 32ncbi.nlm.nih.gov/pmc/articles/PMC4519121/
- 44ncbi.nlm.nih.gov/pmc/articles/PMC7157557/
- 45ncbi.nlm.nih.gov/pmc/articles/PMC7160738/
- 63ncbi.nlm.nih.gov/pmc/articles/PMC5442923/
- 64ncbi.nlm.nih.gov/pmc/articles/PMC5419079/
- 69ncbi.nlm.nih.gov/pmc/articles/PMC4485363/
- 10who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder-(ptsd)
- 12who.int/publications/i/item/9789241519790
- 11samhsa.gov/data/sites/default/files/2020-04/NSDUH-2019-Models-and-Weights.pdf
- 14cdc.gov/violenceprevention/ptsd/index.html
- 28cdc.gov/nchs/data/databriefs/db415.pdf
- 15vizhub.healthdata.org/gbd-results/
- 17jamanetwork.com/journals/jamapsychiatry/fullarticle/1106379
- 19psychiatry.org/Patients-Families/PTSD
- 43psychiatry.org/psychiatrists/practice/clinical-practice-guidelines
- 24icd.who.int/browse/2024-01/mms/en#/6B40
- 25icd.who.int/browse/2024-01/mms/en#/6B41
- 26mentalhealth.va.gov/
- 38nctsn.org/interventions/trauma-focused-cognitive-behavioral-therapy
- 40fda.gov/drugs/resources-information-approved-drugs/sertraline-zoloft
- 41fda.gov/drugs/resources-information-approved-drugs/paroxetine-paxil
- 46cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003388.pub4/full
- 47nice.org.uk/guidance/ng116
- 51pubmed.ncbi.nlm.nih.gov/25255267/
- 52pubmed.ncbi.nlm.nih.gov/19006777/
- 53pubmed.ncbi.nlm.nih.gov/15975311/
- 54pubmed.ncbi.nlm.nih.gov/18317512/
- 56va.gov/health/care-coordination/ptsd/ebp.asp







